Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
2,879
Showing 50 of 2,879
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 201 | STEM | Stem, Inc. | 104/116 | 18 | 84% | +45.2% | +69.0% | +92.2% | -91.1% |
| 202 | MLSS | Milestone Scientific Inc. | 53/82 | 6 | 100% | +45.0% | +43.1% | +77.4% | +5.3% |
| 203 | GETY | Getty Images Holdings, Inc. | 184/253 | 19 | 99% | +45.0% | +46.3% | +66.0% | -35.2% |
| 204 | ANGO | Angiodynamics Inc | 12/15 | 6 | 83% | +44.9% | +58.8% | +89.1% | -43.2% |
| 205 | GEOS | Geospace Technologies Corp | 17 | 4 | 94% | +44.8% | +32.3% | +138.0% | -5.5% |
| 206 | GNLX | Genelux Corp | 118/141 | 14 | 71% | +44.8% | +84.3% | +92.0% | -80.8% |
| 207 | WAY | Waystar Holding Corp. | 68/113 | 20 | 100% | +44.8% | +49.6% | +83.8% | +4.5% |
| 208 | TH | Target Hospitality Corp. | 44/52 | 7 | 98% | +44.7% | +40.6% | +225.0% | -225.0% |
| 209 | HCAT | Health Catalyst, Inc. | 83/87 | 12 | 94% | +44.7% | +46.9% | +74.2% | -40.6% |
| 210 | SYBX | Synlogic, Inc. | 11/12 | 4 | 82% | +44.4% | +51.9% | +79.8% | -49.1% |
| 211 | SSSS | Suro Capital Corp. | 18/25 | 3 | 83% | +44.2% | +43.6% | +155.4% | -63.1% |
| 212 | BIGC | Bigcommerce Holdings, Inc. | 80/114 | 13 | 94% | +44.1% | +56.3% | +80.9% | -80.9% |
| 213 | SRPT | Sarepta Therapeutics, Inc. | 43/45 | 11 | 91% | +43.9% | +57.8% | +89.0% | -84.3% |
| 214 | BKKT | Bakkt Holdings, Inc. | 71/90 | 15 | 94% | +43.8% | +49.1% | +75.3% | -36.4% |
| 215 | TPL | Texas Pacific Land Corp | 5,476/5,899 | 11 | 70% | +43.7% | +20.7% | +203.4% | -49.3% |
| 216 | INTT | Intest Corp | 14/18 | 4 | 71% | +43.5% | +50.9% | +207.7% | -93.9% |
| 217 | IHT | Innsuites Hospitality Trust | 41/67 | 4 | 76% | +42.9% | +54.4% | +102.9% | -28.9% |
| 218 | ORMP | Oramed Pharmaceuticals Inc. | 11 | 6 | 91% | +42.9% | +32.5% | +80.9% | -32.5% |
| 219 | JACK | Jack in the Box Inc | 88/129 | 17 | 97% | +42.9% | +51.6% | +66.8% | -53.8% |
| 220 | ALT | Altimmune, Inc. | 15/25 | 10 | 67% | +42.8% | +68.6% | +119.9% | -69.9% |
| 221 | VAXX | Vaxxinity, Inc. | 70 | 7 | 77% | +42.7% | +49.9% | +99.9% | -74.5% |
| 222 | BILL | Bill Holdings, Inc. | 459/466 | 12 | 92% | +42.5% | +53.9% | +66.8% | -37.8% |
| 223 | CBIO | Crescent Biopharma, Inc. | 132/136 | 22 | 86% | +42.5% | +45.5% | +103.3% | -88.7% |
| 224 | MYGN | Myriad Genetics Inc | 24/29 | 14 | 83% | +42.4% | +69.1% | +84.9% | -39.5% |
| 225 | GANX | Gain Therapeutics, Inc. | 13 | 6 | 85% | +42.4% | +48.8% | +84.1% | -49.9% |
| 226 | GPRO | Gopro, Inc. | 50/58 | 14 | 94% | +42.2% | +43.1% | +64.5% | -31.8% |
| 227 | PLTK | Playtika Holding Corp. | 212 | 14 | 100% | +42.0% | +46.1% | +54.4% | +24.5% |
| 228 | ZIP | Ziprecruiter, Inc. | 172/280 | 21 | 100% | +42.0% | +42.4% | +75.9% | +4.6% |
| 229 | WATT | Energous Corp | 26/28 | 6 | 92% | +41.8% | +39.0% | +90.3% | -81.6% |
| 230 | CDLX | Cardlytics, Inc. | 129/151 | 14 | 78% | +41.7% | +76.6% | +94.5% | -92.5% |
| 231 | PETV | Petvivo Holdings, Inc. | 84/88 | 5 | 56% | +41.5% | +81.1% | +200.9% | -75.5% |
| 232 | LTRX | Lantronix Inc | 39/42 | 14 | 67% | +41.4% | +25.5% | +190.1% | -39.3% |
| 233 | PALT | Paltalk, Inc. | 21/27 | 5 | 86% | +41.3% | +56.6% | +61.0% | -37.2% |
| 234 | BCRX | Biocryst Pharmaceuticals Inc | 26/37 | 17 | 85% | +41.3% | +50.0% | +83.8% | -66.8% |
| 235 | RZLT | Rezolute, Inc. | 46/60 | 9 | 70% | +41.2% | +11.0% | +253.3% | -66.6% |
| 236 | ANTX | An2 Therapeutics, Inc. | 188/200 | 21 | 64% | +41.2% | +93.0% | +287.8% | -308.5% |
| 237 | LC | Lendingclub Corp | 59/83 | 18 | 59% | +41.0% | +42.4% | +180.3% | -72.5% |
| 238 | CGC | Canopy Growth Corp | 40/61 | 11 | 78% | +40.9% | +58.4% | +82.3% | -64.7% |
| 239 | FORR | Forrester Research, Inc. | 16 | 9 | 100% | +40.7% | +43.0% | +48.9% | +25.2% |
| 240 | ORGN | Origin Materials, Inc. | 39/48 | 12 | 69% | +40.6% | +66.2% | +90.2% | -58.9% |
| 241 | MREO | Mereo Biopharma Group PLC | 25 | 6 | 100% | +40.4% | +57.9% | +62.3% | +19.8% |
| 242 | EAST | Eastside Distilling, Inc. | 246/289 | 17 | 89% | +40.3% | +41.8% | +107.0% | -74.0% |
| 243 | GTLS | Chart Industries Inc | 24 | 9 | 96% | +40.1% | +40.3% | +81.3% | -3.6% |
| 244 | AXR | Amrep Corp. | 197/256 | 7 | 81% | +39.9% | +38.4% | +120.7% | -20.6% |
| 245 | RCKT | Rocket Pharmaceuticals, Inc. | 79/113 | 11 | 71% | +39.9% | +56.6% | +86.0% | -46.9% |
| 246 | CART | Maplebear Inc. | 429/501 | 51 | 76% | +39.9% | +55.4% | +91.9% | -94.3% |
| 247 | TWFG | Twfg, Inc. | 22/31 | 10 | 95% | +39.8% | +42.4% | +42.4% | -15.2% |
| 248 | NUS | Nu Skin Enterprises, Inc. | 68/76 | 13 | 97% | +39.6% | +29.5% | +70.4% | -19.0% |
| 249 | BNZI | Banzai International, Inc. | 32/40 | 5 | 72% | +39.4% | +91.3% | +94.5% | -99.1% |
| 250 | ACRS | Aclaris Therapeutics, Inc. | 58/59 | 10 | 86% | +39.4% | +36.1% | +92.9% | -85.4% |